mantle cell lymphoma

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +201 more
Jan 27, 2023

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

    Completed
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    Sep 27, 2022

    DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

    Terminated
    • Diffuse Large B-Cell Lymphoma
    • +4 more
    • Ublituximab
    • +2 more
    • Birmingham, Alabama
    • +167 more
    Jul 20, 2022

    Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)

    Recruiting
    • Diffuse Large B-cell Lymphoma
    • +7 more
    • GEN3009
    • Epcoritamab
    • Tucson, Arizona
    • +31 more
    Jul 1, 2022

    Mantle Cell Lymphoma Trial in United States (lenalidomide, rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Tampa, Florida
    • +3 more
    Mar 26, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +165 more
    Mar 24, 2022

    Collecting and Storing Tissue Samples From Rare or Cutaneous

    Active, not recruiting
    • Adult Immunoblastic Lymphoma
    • +12 more
    • Cytology Specimen Collection Procedure
    • Birmingham, Alabama
    • +129 more
    Mar 23, 2022

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)

    Terminated
    • Mantle Cell Lymphoma
    • Non-Hodgkin's Lymphoma
    • San Diego, California
    • +91 more
    Nov 6, 2019

    Mantle Cell Lymphoma Trial in Worldwide (lenalidomide)

    Completed
    • Mantle Cell Lymphoma
    • Little Rock, Arkansas
    • +69 more
    Dec 11, 2018

    DLBCL, Transformed Follicular Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Alisertib (MLN8237), Rituximab, Vincristine)

    Completed
    • Diffuse Large B-Cell Lymphoma
    • +3 more
    • Alisertib (MLN8237)
    • +2 more
    • Tucson, Arizona
    • +24 more
    Feb 27, 2018

    Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

    Completed
    • Non-Hodgkin's Lymphoma
    • Mantle Cell Lymphoma
    • Tucson, Arizona
    • +127 more
    Jan 8, 2018

    CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in

    Completed
    • CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma
    • +9 more
    • Scottsdale, Arizona
    • +9 more
    Jan 29, 2018

    Lymphoid Malignancies (New or Relapsed), Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Philadelphia (Hyper-CVAD,

    Completed
    • Lymphoid Malignancies (New or Relapsed)
    • +5 more
    • Philadelphia, Pennsylvania
    • +1 more
    Nov 10, 2017

    Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

    Completed
    • Mantle Cell Lymphoma
    • VELCADE TM (bortezomib) for Injection
    • Birmingham, Alabama
    • +34 more
    Feb 7, 2008

    Mantle Cell Lymphoma Trial in Chicago, New York, Philadelphia (Iodine-131 Anti-B1 Antibody, Cyclophosphamide, Doxorubicin,

    Completed
    • Mantle Cell Lymphoma
    • Iodine-131 Anti-B1 Antibody
    • Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)
    • Chicago, Illinois
    • +2 more
    Jun 23, 2005